Drug Profile
MDR1 gene therapy - Ingenex
Latest Information Update: 02 Apr 2007
Price :
$50
*
At a glance
- Originator University of Illinois
- Class Chemoprotectants; Gene therapies
- Mechanism of Action P-glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chemotherapy-induced damage
Most Recent Events
- 25 Jul 2001 Phase-II clinical trials for Chemotherapy induced damage (Prevention)/Chemoprotection in USA (Unknown route)
- 18 Sep 1996 Phase-II clinical trials for Chemotherapy induced damage (Prevention)/Chemoprotection in USA (Unknown route)